These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 6352618

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections.
    Cox CE.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():47-52. PubMed ID: 6352654
    [Abstract] [Full Text] [Related]

  • 24. Ceftazidime in septicaemia.
    Lundbergh P, Jarstrand C, Morfeldt-Månson L, Weiland O.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():199-205. PubMed ID: 6225764
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Complicated urinary tract infections treated with ceftazidime and tobramycin: a comparative study.
    Madsen PO, Frimodt-Møller PC.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():77-9. PubMed ID: 6352658
    [Abstract] [Full Text] [Related]

  • 27. Ceftazidime in the treatment of lower respiratory tract infection.
    Peirce TH, Vig SJ, Ingram PM.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():21-5. PubMed ID: 6352621
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Clinical pharmacologic studies of cephalexin. Influence of renal insufficiency, with or without hemodialytic treatment, on plasma levels. Effectiveness in urinary infection].
    Zech P, Monnier C, Moskovtchenko JF, Traeger J.
    Therapeutique; 1971 Dec; 47(10):885-90. PubMed ID: 5145555
    [No Abstract] [Full Text] [Related]

  • 37. Ceftazidime: pharmacokinetics in young volunteers versus elderly patients and therapeutic efficacy with complicated urinary tract infections.
    Naber KG, Kees F, Grobecker H.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():41-5. PubMed ID: 6352653
    [Abstract] [Full Text] [Related]

  • 38. [Usefulness of ceftazidime in intractable respiratory tract infections].
    Takenaka S, Fukuda K, Kimura T, Shima K, Ushijima M, Egashira Y, Ikeda S, Hiraoka T, Higuchi S, Fujise T.
    Jpn J Antibiot; 1989 Dec; 42(12):2555-65. PubMed ID: 2693754
    [Abstract] [Full Text] [Related]

  • 39. [Clinical study on ceftazidime in the field of pediatrics].
    Minamitani M, Hachimori K, Kaneda K.
    Jpn J Antibiot; 1984 Mar; 37(3):377-88. PubMed ID: 6376851
    [Abstract] [Full Text] [Related]

  • 40. An open study of ceftazidime in the treatment of serious bacterial infection.
    Allan SG, Glover SC, Smith CC, Hadley KM, Reid TM, Han K, Murdoch JM, Ingram PM.
    J Antimicrob Chemother; 1983 Sep; 12(3):219-27. PubMed ID: 6355044
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.